Chapter
Antibodies and variants of concern
1:02:17 - 1:11:05 (08:48)
Antibodies may be less successful in fighting off new variants of COVID-19, but the chances of someone who has been double vaccinated getting infected and transmitting the virus is so remote that it is not worth considering.
Clips
The success of a country in battling COVID-19 is about how fast they can get their population vaccinated.
1:02:17 - 1:03:24 (01:07)
Summary
The success of a country in battling COVID-19 is about how fast they can get their population vaccinated. Israel, with successful vaccination rates, has seen a decrease in their cases, while the US is slipping due to people not showing up for appointments amidst vaccine scare stories perpetuated by the media.
ChapterAntibodies and variants of concern
EpisodeE30: Ramifications of Biden's proposed capital gains tax hike, federal budget, India's COVID surge, founder psychology & more
PodcastAll-In with Chamath, Jason, Sacks & Friedberg
The probability for a double vaccinated individual to contract and transmit the virus is so low that it is not even worth considering, highlighting the importance of depoliticizing the spread reduction of the virus.
1:03:24 - 1:08:22 (04:57)
Summary
The probability for a double vaccinated individual to contract and transmit the virus is so low that it is not even worth considering, highlighting the importance of depoliticizing the spread reduction of the virus.
ChapterAntibodies and variants of concern
EpisodeE30: Ramifications of Biden's proposed capital gains tax hike, federal budget, India's COVID surge, founder psychology & more
PodcastAll-In with Chamath, Jason, Sacks & Friedberg
Variants of concern may differ slightly from most antibodies you have, however, it does not necessarily mean you won't be able to fight them off with the antibodies you have produced.
1:08:22 - 1:11:05 (02:43)
Summary
Variants of concern may differ slightly from most antibodies you have, however, it does not necessarily mean you won't be able to fight them off with the antibodies you have produced. The success of your antibodies will define your success in fighting off a specific variant of SARS-CoV-2 where the spike protein is changing slightly with each variant.